Literature DB >> 2670594

Long-term culturing of TPA-induced differentiated HL-60 cells results in increased levels of lytic enzymes.

J J Ackerman1, J A Duerre.   

Abstract

After exposure to 12-O-tetradecanoylphorbol-13-acetate (TPA), cells of the promyelocytic leukemia cell line, HL-60, differentiate into macrophage-like cells. Within 24 h the cells adhere to the surface of the culture flask and increase production of nonspecific esterases. The intracellular concentration of the serine proteases increases two- to threefold within 4 days and continues to increase as the cells develop into mature macrophages. The acid hydrolases, lysozyme and beta-glucuronidase, were secreted by the differentiated cells. Both the intracellular and extracellular concentrations of these enzymes continued to increase as the cells matured. The fully differentiated cells readily phagocytized opsonized yeast cells. Phagocytosis had little effect on the secretion of acid hydrolases, while intracellular proteases increased significantly. The fully differentiated HL-60 cells resembled normal macrophages regarding all parameters studied. Viability of the differentiated cells exceeded 50% when cultured for 30 days. Therefore, these cells should prove to be a useful tool for the study of macrophage function with respect to microorganisms that are resistant to destruction by phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670594     DOI: 10.1016/0014-4827(89)90396-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  2 in total

1.  Rabies virus replication in primary murine bone marrow macrophages and in human and murine macrophage-like cell lines: implications for viral persistence.

Authors:  N B Ray; L C Ewalt; D L Lodmell
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

2.  Quantitative GPCR and ion channel transcriptomics in primary alveolar macrophages and macrophage surrogates.

Authors:  Paul J Groot-Kormelink; Lindsay Fawcett; Paul D Wright; Martin Gosling; Toby C Kent
Journal:  BMC Immunol       Date:  2012-10-26       Impact factor: 3.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.